ATE390124T1 - Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin - Google Patents

Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin

Info

Publication number
ATE390124T1
ATE390124T1 AT03782368T AT03782368T ATE390124T1 AT E390124 T1 ATE390124 T1 AT E390124T1 AT 03782368 T AT03782368 T AT 03782368T AT 03782368 T AT03782368 T AT 03782368T AT E390124 T1 ATE390124 T1 AT E390124T1
Authority
AT
Austria
Prior art keywords
prednisolone
treatment
mastitis
cephalosporin
combination
Prior art date
Application number
AT03782368T
Other languages
English (en)
Inventor
Peter Gerardus Franciscus Cox
Joseph Lohuis
Selma Hensen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32524018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE390124(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Application granted granted Critical
Publication of ATE390124T1 publication Critical patent/ATE390124T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT03782368T 2002-12-16 2003-12-10 Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin ATE390124T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02080265 2002-12-16

Publications (1)

Publication Number Publication Date
ATE390124T1 true ATE390124T1 (de) 2008-04-15

Family

ID=32524018

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03782368T ATE390124T1 (de) 2002-12-16 2003-12-10 Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin

Country Status (9)

Country Link
US (1) US7812009B2 (de)
EP (1) EP1585497B1 (de)
JP (2) JP5162080B2 (de)
AT (1) ATE390124T1 (de)
AU (1) AU2003290015A1 (de)
CA (1) CA2508022C (de)
DE (1) DE60320034T2 (de)
ES (1) ES2300634T3 (de)
WO (1) WO2004054538A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2300634T3 (es) * 2002-12-16 2008-06-16 Intervet International Bv Tratamiento de mastitis con una combinacion de prednisolona con cefalosporina.
CN100368016C (zh) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 治疗奶牛乳房炎的乳房灌注液及其制备方法
JP5322649B2 (ja) * 2005-10-29 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー セフキノム組成物およびその使用方法
CA2661099C (en) * 2006-08-30 2012-01-24 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
CN101148451A (zh) * 2007-05-16 2008-03-26 好维股份有限公司 一种口腔药物及口腔护理用品
EP2512504A4 (de) * 2009-12-15 2013-06-19 Dec Int Nz Ltd Behandlungszusammensetzung und -verfahren
EP2510944A1 (de) * 2011-04-15 2012-10-17 National University of Ireland, Galway Behandlung von Bakterieninfektionen
RU2013155085A (ru) * 2011-05-12 2015-06-20 Интервет Интернэшнл Б.В. Лечение мастита
AU2013201147A1 (en) 2012-02-27 2013-09-12 Bayer New Zealand Limited Controlled release compositions and their methods of use
AU2014266266B2 (en) * 2013-05-17 2019-05-16 Asahi Biocycle Co., Ltd. Preventive or therapeutic agent for ruminant animal mastitis
RU2018107214A (ru) 2015-07-29 2019-08-29 ДЖИНЕС, ПиЭлСи Способ разведения коров для повышения надоев молока
EP3603645A1 (de) 2018-07-30 2020-02-05 Virbac Neuartige verwendung von glucocorticoiden zur behandlung von epithelialen mikrobiellen infektionen eines flüssigkeitshaltigen organs mit einer natürlichen äusseren öffnung in säugetieren
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52110816A (en) * 1976-03-15 1977-09-17 Takeda Chem Ind Ltd Medicines
AU504840B2 (en) 1975-09-09 1979-11-01 Takeda Chemical Industries Ltd Medicinal compositions
JPS5234914A (en) * 1975-09-09 1977-03-17 Takeda Chem Ind Ltd Method and composition for preventing failing of milk secretion of live stocks
ES2300634T3 (es) * 2002-12-16 2008-06-16 Intervet International Bv Tratamiento de mastitis con una combinacion de prednisolona con cefalosporina.

Also Published As

Publication number Publication date
ES2300634T3 (es) 2008-06-16
DE60320034D1 (de) 2008-05-08
CA2508022C (en) 2012-01-31
JP2013035845A (ja) 2013-02-21
US20060058273A1 (en) 2006-03-16
CA2508022A1 (en) 2004-07-01
EP1585497A1 (de) 2005-10-19
US7812009B2 (en) 2010-10-12
JP2006514642A (ja) 2006-05-11
WO2004054538A1 (en) 2004-07-01
JP5162080B2 (ja) 2013-03-13
DE60320034T2 (de) 2009-05-14
AU2003290015A1 (en) 2004-07-09
EP1585497B1 (de) 2008-03-26

Similar Documents

Publication Publication Date Title
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
WO2004060882A8 (en) Cb 1/cb 2 receptor ligands and their use in the treatment of pain
DK1294383T3 (da) Orale sammensætninger omfattende antimikrobielle midler til at forhindre systemiske sygdomme
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
DK0740650T3 (da) Codrugs som metode til styret transport af lægemiddel
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
HK1095139A1 (en) Azabicyclic heterocycles as cannabinoid receptor modulators
GEP20063799B (en) Tropane derivatives useful in therapy
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
HK1073252A1 (en) Use of antiseptics in the manufacture of a pharmaceutical preparation for the prevention or treatment of inflammations in the interior of the human body
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
SE9903997D0 (sv) New compounds
NO20043792L (no) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
DE69943239D1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
SE0000303D0 (sv) Novel compounds
ATE241640T1 (de) Fusidinsäure-derivate
DE60130253D1 (de) Zusammensetzungen zur verhinderung der adhäsion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1585497

Country of ref document: EP